|By PR Newswire||
|August 25, 2014 04:01 PM EDT||
NEWARK, Calif., Aug. 25, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Morgan Stanley 2014 Global Healthcare Conference in New York City.
The presentation at the Morgan Stanley conference is scheduled for 2:40 pm ET (11:40 am PT) on Wednesday September 10, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for 30 days on the company's website.
Depomed is a specialty pharmaceutical company that commercializes products for pain and CNS disorders. Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia. CAMBIA® (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks with or without aura in adults (18 years of age or older). Zipsor® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain in adults. Lazanda® (fentanyl) Nasal Spray is an intranasal fentanyl drug used to manage breakthrough pain in adults (18 years of age or older) who are already routinely taking other opioid pain medicines around-the-clock for cancer pain. Gralise and various partner product candidates are formulated with Depomed's proven, proprietary Acuform® drug delivery technology. Additional information about Depomed may be found at www.depomed.com.
August J. Moretti
Depomed, Inc. 510.744.8000
SOURCE Depomed, Inc.
Dec. 7, 2016 07:30 AM EST Reads: 809
Dec. 7, 2016 06:45 AM EST Reads: 1,988
Dec. 7, 2016 06:30 AM EST Reads: 1,800
Dec. 7, 2016 06:15 AM EST Reads: 5,325
Dec. 7, 2016 05:15 AM EST Reads: 1,054
Dec. 7, 2016 04:00 AM EST Reads: 866
Dec. 7, 2016 02:00 AM EST Reads: 625
Dec. 7, 2016 01:45 AM EST Reads: 6,163
Dec. 7, 2016 01:15 AM EST Reads: 1,879
Dec. 7, 2016 01:00 AM EST Reads: 1,617
Dec. 7, 2016 12:45 AM EST Reads: 3,938
Dec. 7, 2016 12:45 AM EST Reads: 1,244
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
Dec. 7, 2016 12:15 AM EST Reads: 1,033
Dec. 7, 2016 12:15 AM EST Reads: 1,377
The Internet of Things (IoT) promises to simplify and streamline our lives by automating routine tasks that distract us from our goals. This promise is based on the ubiquitous deployment of smart, connected devices that link everything from industrial control systems to automobiles to refrigerators. Unfortunately, comparatively few of the devices currently deployed have been developed with an eye toward security, and as the DDoS attacks of late October 2016 have demonstrated, this oversight can ...
Dec. 7, 2016 12:00 AM EST Reads: 1,278